Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $6.27 Million - $9.85 Million
105,000 New
105,000 $6.93 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $617,100 - $777,600
10,000 New
10,000 $762,000
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $2.97 Million - $4.4 Million
34,300 New
34,300 $3.26 Million
Q2 2019

Aug 13, 2019

SELL
$55.74 - $64.41 $1.67 Million - $1.93 Million
-30,000 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $1.44 Million - $1.92 Million
30,000 New
30,000 $5.74 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.